Data publikacji: 21 sty 2021
Zakres stron: 3 - 7
Otrzymano: 23 paź 2019
Przyjęty: 08 wrz 2020
DOI: https://doi.org/10.2478/jbcr-2020-0001
Słowa kluczowe
© 2020 Martin P. Karamanliev et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Total mesorectal excision (TME) has become the golden standard for treating rectal cancer since Heald introduced it [1]. Transanal total mesorectal excision (taTME) is an innovative surgical method for rectal cancer. A nonsystematic literature review on the articles on taTME in the PubMed and Scopus database was performed. ‘TaTME’ and ‘transanal total mesorectal excision’ keywords were used. The search was restricted to articles in English on more than 25 patients analyzed and followed-up. Fourteen articles were identified, most of them from Europe and China. Of these, eight were original studies, and six were systematic reviews and meta-analyses. TaTME is safe and efficient in experienced hands. It could be superior to laparoscopic total mesorectal excision (laTME) concerning perioperative complications. Its advantages in oncological outcomes over laTME are to be proven in structured randomized clinical trials (RCTs).